# DIBBS #SPE2DP-26-T-5291

DLA solicitation for 67 bottles of moxifloxacin hydrochloride tablets

**Posted:** September 29, 2026
**Respond By:** October 05, 2026
**Identifier:** SPE2DP-26-T-5291
**NAICS:** 424210, 325412

DLA Troop Support is seeking bottles of prescription moxifloxacin hydrochloride tablets for its Medical Supply Chain Pharm FSA.
- **Government buyer:** Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA; procurement contact: Vanesa M Carbo Acevedo.
- **Product requested:** 67 bottles of moxifloxacin hydrochloride, 400 mg tablets, 30 tablets per bottle; NSN 6505-01-503-4772. The total spans seven requisitions, with quantities of 4, 24, 1, 1, 25, 2, and 10 bottles.
- **Named approved-source manufacturers/OEMs:** **TEVA Pharmaceuticals USA, Inc.** (NDC00093-7387-56) and **Rising Pharma Holdings, Inc.** (NDC57237-0156-30).
- **Notable requirements:** FDA-regulated product; 36-month non-extendable shelf life; store at controlled room temperature and protect from high humidity. Delivery is required within 5 days after order.

### Description

MOXIFLOXACIN HYDROC (QTY: 4, NSN: 6505-01-503-4772, Purchase Request: 7007458174)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7018517863)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 10, NSN: 6505-01-503-4772, Purchase Request: 7007423083)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 24, NSN: 6505-01-503-4772, Purchase Request: 7006831542)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 25, NSN: 6505-01-503-4772, Purchase Request: 7018536597)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 2, NSN: 6505-01-503-4772, Purchase Request: 7006032424)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 
MOXIFLOXACIN HYDROC (QTY: 1, NSN: 6505-01-503-4772, Purchase Request: 7018540426)
  Approved Sources:
  - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC.
  - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.
 

[View original listing](https://www.dibbs.bsm.dla.mil/rfq/rfqrec.aspx?sn=SPE2DP26T5291)